Usefulness of Proteinuria as a Prognostic Marker of Mortality and Cardiovascular Events Among Patients Undergoing Percutaneous Coronary Intervention (Data from the Evaluation of Oral Xemilofiban in Controlling Thrombotic Events [EXCITE] Trial)
| Autor: | Mercado, Nestor a, Brugts, Jasper J. b, ⁎, Ix, Joachim H. c, Shlipak, Michael G. b, d, e, f, Dixon, Simon R. g, Gersh, Bernard J. h, Lemos, Pedro A. i, Guarneri, Mimi a, Teirstein, Paul S. a, Wijns, William j, Serruys, Patrick W. b, Boersma, Eric b, O'Neill, William W. k |
|---|---|
| Zdroj: | In The American Journal of Cardiology 2008 102(9):1151-1155 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect